The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of the postneoadjuvant therapy pathological stage of the American Joint Committee on Cancer (AJCC) 8th Edition for predicting outcomes of esophageal squamous cell carcinoma (ESCC) patients receiving neoadjuvant chemoradiotherapy (CRT) followed by esophagectomy.
 
Tsung-hao Liu
No Relationships to Disclose
 
Hung-Yang Kuo
No Relationships to Disclose
 
Jhe-Cyuan Guo
No Relationships to Disclose
 
Chia-Chi Lin
Honoraria - Lilly; Merck Sharp & Dohme
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
Travel, Accommodations, Expenses - Lilly
 
Ta-Chen Huang
No Relationships to Disclose
 
Min-Shu Hsieh
No Relationships to Disclose
 
Jang-Ming Lee
No Relationships to Disclose
 
Chih-Hung Hsu
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Lilly; MSD; Novartis; Ono Pharmaceutical
Research Funding - AstraZeneca; MSD; Ono Pharmaceutical